AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H101. A total of 175 filers reported holding AMYLYX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $489,097 | -15.1% | 26,712 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $576,178 | -26.5% | 26,712 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $783,730 | -20.6% | 26,712 | 0.0% | 0.01% | -25.0% |
| Q4 2022 | $987,008 | +80.2% | 26,712 | +37.3% | 0.01% | +60.0% |
| Q3 2022 | $547,827 | +319.2% | 19,461 | +186.8% | 0.01% | +400.0% |
| Q2 2022 | $130,679 | +49.9% | 6,785 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $87,187 | – | 6,785 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpha Wave Global, LP | 930,337 | $27,296,088 | 10.08% |
| Perceptive Advisors | 6,034,644 | $177,056,455 | 5.23% |
| GREAT POINT PARTNERS LLC | 783,795 | $22,996,545 | 4.52% |
| Ghost Tree Capital, LLC | 475,000 | $13,937,000 | 4.12% |
| Altium Capital Management LP | 185,000 | $5,427,900 | 3.01% |
| Boxer Capital, LLC | 2,084,000 | $61,145 | 3.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 789,591 | $23,166,600 | 1.37% |
| EMERALD ADVISERS, LLC | 972,835 | $28,542,979 | 1.37% |
| SECTORAL ASSET MANAGEMENT INC | 242,400 | $7,112,016 | 1.37% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,984,333 | $58,220,330 | 1.30% |